The Schedule of Pharmaceutical Benefits has been updated. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- Removal of prescriber accreditation requirements under the PBS Highly Specialised Drugs Program for medicines for the treatment of hepatitis B and hepatitis C - 1 September 2026
- Recommendations made by the PBAC – May 2026 Intracycle Meeting - 1 September 2026
- PBS Schedule PDFs – changes to improve accessibility and efficiency - 1 September 2026
- Active Ingredient Prescribing - 1 September 2026
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 September 2026
- Ex-manufacturer price - 1 September 2026
- Medicine Status Website - 1 September 2026
- Item Delist Submission deadline cut-off dates for PBAC meetings changing in 2027 - 31 August 2026
- Minimum Stockholding Requirements - 31 August 2026
- Designated Brands - 31 August 2026
- Medicines Supply Security Guarantee - 31 August 2026
- Agenda for the September 2026 PBAC Meeting - 28 August 2026
- PSA calls for pharmacists to shape dispensing practice guidelines - 27 August 2026
- PSA seeking to strengthen governance in pharmacy practice - 27 August 2026
- Rapid review of PBS medicines for relapsing-remitting multiple sclerosis (RRMS) - 21 August 2026
- Minimum Stockholding Requirements - 18 August 2026
- Designated Brands - 18 August 2026
- Cost Recovery Fees and Charges - 18 August 2026
- PBS and RPBS Date of Supply Data - 14 August 2026
- PBAC Update July 2026 - 14 August 2026
- PBS subsidy arrangements for dapsone tablets SSSI - 14 August 2026
- Rapid review of PBS medicines for relapsing-remitting multiple sclerosis (RRMS) - 11 August 2026
- Monitoring system for final trial overall survival results for cancer medicines - 4 August 2026